ICON Price to Book Ratio 2010-2025 | ICLR
Historical price to book ratio values for ICON (ICLR) over the last 10 years. The current price to book ratio for ICON as of June 27, 2025 is 1.23.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ICON Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-06-27 | 144.56 | 1.21 | |
| 2025-03-31 | 174.99 | $119.56 | 1.46 |
| 2024-12-31 | 209.71 | $117.92 | 1.78 |
| 2024-09-30 | 287.31 | $118.39 | 2.43 |
| 2024-06-30 | 313.47 | $115.74 | 2.71 |
| 2024-03-31 | 335.95 | $114.08 | 2.94 |
| 2023-12-31 | 283.07 | $112.02 | 2.53 |
| 2023-09-30 | 246.25 | $108.82 | 2.26 |
| 2023-06-30 | 250.20 | $107.08 | 2.34 |
| 2023-03-31 | 213.59 | $105.63 | 2.02 |
| 2022-12-31 | 194.25 | $103.98 | 1.87 |
| 2022-09-30 | 183.78 | $100.91 | 1.82 |
| 2022-06-30 | 216.70 | $99.92 | 2.17 |
| 2022-03-31 | 243.22 | $99.26 | 2.45 |
| 2021-12-31 | 309.70 | $98.91 | 3.13 |
| 2021-09-30 | 262.02 | $97.90 | 2.68 |
| 2021-06-30 | 206.71 | $38.29 | 5.40 |
| 2021-03-31 | 196.37 | $36.59 | 5.37 |
| 2020-12-31 | 194.98 | $35.05 | 5.56 |
| 2020-09-30 | 191.09 | $32.42 | 5.89 |
| 2020-06-30 | 168.46 | $29.99 | 5.62 |
| 2020-03-31 | 136.00 | $28.83 | 4.72 |
| 2019-12-31 | 172.23 | $30.91 | 5.57 |
| 2019-09-30 | 147.34 | $28.66 | 5.14 |
| 2019-06-30 | 153.97 | $28.27 | 5.45 |
| 2019-03-31 | 136.58 | $26.35 | 5.18 |
| 2018-12-31 | 129.21 | $25.09 | 5.15 |
| 2018-09-30 | 153.75 | $24.51 | 6.27 |
| 2018-06-30 | 132.53 | $22.80 | 5.81 |
| 2018-03-31 | 118.14 | $22.40 | 5.27 |
| 2017-12-31 | 112.15 | $22.02 | 5.09 |
| 2017-09-30 | 113.88 | $20.82 | 5.47 |
| 2017-06-30 | 97.79 | $19.05 | 5.13 |
| 2017-03-31 | 79.72 | $17.56 | 4.54 |
| 2016-12-31 | 75.20 | $17.33 | 4.34 |
| 2016-09-30 | 77.37 | $17.77 | 4.35 |
| 2016-06-30 | 70.01 | $16.41 | 4.27 |
| 2016-03-31 | 75.10 | $15.32 | 4.90 |
| 2015-12-31 | 77.70 | $13.88 | 5.60 |
| 2015-09-30 | 70.97 | $15.08 | 4.71 |
| 2015-06-30 | 67.30 | 0.00 | |
| 2015-03-31 | 70.53 | 0.00 | |
| 2014-12-31 | 50.99 | $15.81 | 3.23 |
| 2014-09-30 | 57.23 | 0.00 | |
| 2014-06-30 | 47.11 | 0.00 | |
| 2014-03-31 | 47.55 | 0.00 | |
| 2013-12-31 | 40.42 | $14.79 | 2.73 |
| 2013-09-30 | 40.93 | 0.00 | |
| 2013-06-30 | 35.43 | 0.00 | |
| 2013-03-31 | 32.29 | 0.00 | |
| 2012-12-31 | 27.76 | 0.00 | |
| 2012-09-30 | 24.37 | 0.00 | |
| 2012-06-30 | 22.53 | 0.00 | |
| 2012-03-31 | 21.22 | 0.00 | |
| 2011-12-31 | 17.11 | 0.00 | |
| 2011-09-30 | 16.08 | 0.00 | |
| 2011-06-30 | 23.56 | 0.00 | |
| 2011-03-31 | 21.59 | 0.00 | |
| 2010-12-31 | 21.90 | 0.00 | |
| 2010-09-30 | 21.62 | 0.00 | |
| 2010-06-30 | 28.89 | 0.00 | |
| 2010-03-31 | 26.41 | 0.00 | |
| 2009-12-31 | 21.73 | 0.00 | |
| 2009-09-30 | 24.49 | 0.00 | |
| 2009-06-30 | 21.58 | 0.00 | |
| 2009-03-31 | 16.15 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.674B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.275B | 26.68 |
| CVS Health (CVS) | United States | $86.641B | 10.77 |
| Elevance Health (ELV) | United States | $86.192B | 11.12 |
| Cencora (COR) | United States | $58.034B | 20.19 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.934B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.811B | 17.69 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.798B | 0.00 |
| Solventum (SOLV) | United States | $13.056B | 13.82 |
| CochLear (CHEOY) | Australia | $12.649B | 0.00 |
| Revvity (RVTY) | United States | $11.530B | 19.84 |
| Viatris (VTRS) | United States | $10.575B | 3.63 |
| Avantor (AVTR) | United States | $9.220B | 13.40 |
| HealthEquity (HQY) | United States | $9.070B | 39.73 |
| Medpace Holdings (MEDP) | United States | $8.930B | 23.72 |
| Sonic Healthcare (SKHHY) | Australia | $8.455B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.368B | 14.44 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.386B | 25.83 |
| BrightSpring Health Services (BTSG) | United States | $4.138B | 37.97 |
| Sotera Health (SHC) | United States | $3.213B | 18.26 |
| Surgery Partners (SGRY) | United States | $2.813B | 36.58 |
| Alignment Healthcare (ALHC) | United States | $2.740B | 0.00 |
| Concentras Parent (CON) | United States | $2.711B | 15.67 |
| GeneDx Holdings (WGS) | United States | $2.599B | 100.11 |
| Organon (OGN) | United States | $2.563B | 2.72 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Ardent Health (ARDT) | United States | $1.957B | 8.34 |
| Progyny (PGNY) | United States | $1.878B | 41.34 |
| Premier (PINC) | United States | $1.779B | 13.51 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.475B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.205B | 9.17 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| CareDx (CDNA) | United States | $1.071B | 16.72 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.799B | 7.48 |
| Nutex Health (NUTX) | United States | $0.683B | 10.34 |
| LifeMD (LFMD) | United States | $0.625B | 0.00 |
| Embecta (EMBC) | United States | $0.563B | 3.80 |
| InnovAge Holding (INNV) | United States | $0.529B | 0.00 |
| Enhabit (EHAB) | United States | $0.484B | 39.83 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.57 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.313B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.259B | 0.00 |
| Beauty Health (SKIN) | United States | $0.246B | 0.00 |
| So-Young (SY) | China | $0.240B | 0.00 |
| Oncology Institute (TOI) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| Sera Prognostics (SERA) | United States | $0.154B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.120B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.092B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |